Sirtuin insights: bridging the gap between cellular processes and therapeutic applications.

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Organisms face challenges from environmental changes, stress, and metabolic fluctuations, often leading to pathological conditions, notably cancer.
• Sirtuins (SIRTs), a class of NAD+-dependent enzymes, play crucial roles in cellular processes and are implicated in various diseases.
• The diverse functions and substrate specificities of SIRT isoforms highlight their significance in both normal cellular functions and disease pathogenesis.

Purpose of the Study:

• To detail the distinct roles of SIRT isoforms in cancer, identifying them as potential promoters or suppressors.
• To explore the influence of natural and synthetic compounds on SIRT function for therapeutic applications.
• To provide a comprehensive overview of SIRTs, linking them to diseases and their potential in targeted therapies and personalized medicine.

Main Methods:

• Literature review and synthesis of existing research on SIRT isoforms.
• Analysis of studies investigating the impact of natural and synthetic compounds on SIRT activity.
• Exploration of data on SIRT involvement in various pathological conditions, including cancer.

Main Results:

• SIRT isoforms exhibit dual roles in cancer, acting as either promoters or suppressors depending on the context.
• Natural and synthetic compounds demonstrate potential in modulating SIRT function, suggesting therapeutic avenues.
• Lesser-studied SIRT isoforms, such as SIRT6 and SIRT7, possess unique functions requiring further investigation.

Conclusions:

• Sirtuins are critical regulators of cellular processes and disease, particularly cancer.
• Targeted modulation of SIRT activity using specific inhibitors or activators holds promise for treating diseases with unmet needs.
• Further research into SIRT isoforms and their interactions with compounds can drive innovative therapeutic strategies and personalized medicine.